The purpose of this study is to test the impact of non-invasive brain stimulation, transcranial direct current stimulation (tDCS), on auditory hallucinations, negative symptoms and cognition in schizophrenia. Clinical measures will be used to assess clinical symptoms and cognitive performance to test the hypothesis that a course of tDCS can reduce auditory hallucinations and negative symptoms in schizophrenia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Symptom Severity of Auditory Hallucinations
Timeframe: Assessment begins with the initial baseline interview and concludes after a 2-week follow-up assessment using the same clinical measures.
Change in Symptom Severity of Negative Symptoms
Timeframe: Assessment begins with the initial baseline interview and concludes after a 2-week follow-up assessment using the same clinical measures.